Zimbabwe has declined a substantial US healthcare agreement worth $367m (272 million pounds) over five years due to the United States' insistence on sensitive biological samples.
This rejection came to light after a internal memorandum from December was leaked, indicating that President Emmerson Mnangagwa believed the agreement was "unbalanced".
A government representative has since clarified that the US was requesting health data for research and commercial gain but refused to guarantee the benefits from any future medical innovations.
"We must now begin the challenging and unfortunate task of ending our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had provided over $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has urged more talks to secure a agreement agreeable to all parties so the country's critical HIV treatment initiative can proceed.
Broader Implications
This rejection follows a similar case in neighbouring Kenya, where a high court suspended a similar health funding agreement following legal challenges were filed about the security of Kenyans' health data.
After resuming office last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
USAID had administered assistance for the American government, but Trump claimed its spending was "wasteful" and his administration was pursuing government-to-government deals to enhance openness and responsibility.
As per statements, 16 African countries have to date agreed to these new health pacts, constituting more than $18.3bn in new funding.
Details of the Rejected Deal
The funds for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation would have delivered extraordinary advantages for Zimbabwean communities, especially the 1.2 million currently on antiretroviral therapy via American-funded programmes," the Ambassador said.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"Our nation was requested to share its genetic material and health information over an extended period, with no equivalent guarantee of benefiting from any medical innovations – like new medicines or tests – that could be developed from that provided information," Mangwana explained.
"In essence, our nation would supply the raw materials for scientific discovery with no assurance that the end products would be available to our citizens should a new disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were disrupting systems already established via the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to manage potential pandemics.
"This framework is designed to guarantee that when a country contributes its data, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We are open to further discussions with our American counterparts on how future co-operation could be designed in a way that honours the sovereignty and dignity of each country."
Health Experts Response
Medical experts said it understood the official position, but urged that talks must proceed given that much of the country's Aids initiatives were funded by international support.
"In cases where technical issues arise, such as those involving data governance or implementation frameworks, these can often be addressed through technical clarification and negotiated safeguards," the group added.
The halted deal underscores the continuing challenges between accepting crucial international aid and protecting national sovereignty in an increasingly interconnected world.